
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $263.6M | -- | -- | $2.34 | -- |
08/01/2025 | Q2 | $257.4M | -- | -- | $2.05 | -- |
04/30/2025 | Q1 | $247.3M | $276M | $2.50 | $1.87 | $0.63 |
02/13/2025 | Q4 | $250.7M | $253.6M | -$3.67 | $2.35 | -$6.02 |
11/05/2024 | Q3 | $258.4M | $290.2M | $2.65 | $1.74 | $0.91 |
08/01/2024 | Q2 | $268.5M | $268.9M | $1.33 | $1.42 | -$0.09 |
05/02/2024 | Q1 | $270.4M | $256.6M | $3.74 | $1.09 | $2.66 |
12/31/2023 | Q4 | $261.6M | $295.1M | -$6.21 | $0.91 | -$7.12 |
09/30/2023 | Q3 | $268M | $281.5M | $1.05 | $1.03 | $0.02 |
06/30/2023 | Q2 | $261.8M | $292.4M | $1.95 | $0.29 | $1.67 |
03/31/2023 | Q1 | $250.9M | $275.9M | -$5.34 | -$0.29 | -$5.05 |
12/31/2022 | Q4 | -- | $265.4M | -$8.74 | -- | -- |
09/30/2022 | Q3 | -- | $263.4M | $4.17 | -- | -- |
06/30/2022 | Q2 | -- | $231.8M | $1.11 | -- | -- |
03/31/2022 | Q1 | -- | $238.7M | $6.01 | -- | -- |
12/31/2021 | Q4 | -- | $304.4M | -$0.21 | -- | -- |
09/30/2021 | Q3 | -- | $291M | $2.29 | -- | -- |
06/30/2021 | Q2 | -- | $269.6M | -$1.15 | -- | -- |
03/31/2021 | Q1 | -- | $211.5M | $0.96 | -- | -- |
12/31/2020 | Q4 | -- | $234.1M | -$0.83 | -- | -- |
09/30/2020 | Q3 | -- | $252.8M | -$1.09 | -- | -- |
06/30/2020 | Q2 | -- | $230.6M | $0.23 | -- | -- |
03/31/2020 | Q1 | -- | $259.2M | -$2.84 | -- | -- |
12/31/2019 | Q4 | -- | $266.2M | $3.90 | -- | -- |
09/30/2019 | Q3 | -- | $287.6M | -$4.77 | -- | -- |
06/30/2019 | Q2 | -- | $278.2M | -$10.05 | -- | -- |
03/31/2019 | Q1 | -- | $308.4M | -$4.95 | -- | -- |
12/31/2018 | Q4 | -- | $314.9M | -$0.30 | -- | -- |
09/30/2018 | Q3 | -- | $242.2M | -$4.65 | -- | -- |
06/30/2018 | Q2 | -- | $256.9M | -$3.30 | -- | -- |
03/31/2018 | Q1 | -- | $263M | $0.30 | -- | -- |
12/31/2017 | Q4 | -- | $283.3M | -$5.10 | -- | -- |
09/30/2017 | Q3 | -- | $295.3M | -$0.75 | -- | -- |
06/30/2017 | Q2 | -- | $316.6M | -$5.40 | -- | -- |
03/31/2017 | Q1 | -- | $325.9M | -$3.90 | -- | -- |
12/31/2016 | Q4 | -- | $329.3M | -$1.20 | -- | -- |
09/30/2016 | Q3 | -- | $370.3M | $1.20 | -- | -- |
06/30/2016 | Q2 | -- | $379M | -$10.65 | -- | -- |
03/31/2016 | Q1 | -- | $336.1M | -$13.50 | -- | -- |
12/31/2015 | Q4 | -- | $350.4M | -$26.85 | -- | -- |
09/30/2015 | Q3 | -- | $451.9M | -$7.95 | -- | -- |
Onity Group reported $276M worth of top line sales in its most recent quarter.
Onity Group announced earnings per share of $2.50 which represents a beat of analyst forecast a $1.87 per share.
Onity Group reported $138.6M that represents $16.43 per share over the last quarter.
Onity Group's earnings are forecast to grow from $4.13 per share to $11.33 per share next year representing an increase of 157.57%.
Onity Group's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.